Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02554253Phase 2Completed
A Phase 2 trial of ketamine in Post-operative cognitive dysfunction (POCD), delirium, acute kidney injury (AKI), sponsored by Mayo Clinic. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02554253.